Quality of life (QOL) results of a randomized study of intravenous (IV) paclitaxel and cisplatin vs IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5026-5026
2004 ◽
Vol 22
(14_suppl)
◽
pp. 5026-5026
◽
2017 ◽
Vol 147
(1)
◽
pp. 98-103
◽
Keyword(s):
2010 ◽
Vol 39
(5)
◽
pp. 839-846
◽
2012 ◽
Vol 124
(3)
◽
pp. 379-382
◽
2015 ◽
Vol 136
(2)
◽
pp. 293-299
◽
2018 ◽
Vol 150
(1)
◽
pp. 119-126
◽
2010 ◽
Vol 10
(7)
◽
pp. 987-991
◽
Keyword(s):
Keyword(s):